Lilov Alexander, Palaveev Kiril, Mitev Vanyo
Pulmonology, Specialized Hospital for Active Treatment Pneumo-Pneumonia-Phthisiatric Diseases (SHATPPD) "Sofia District" Hospital, Sofia, BGR.
Chemistry and Biochemistry, Medical University of Sofia, Sofia, BGR.
Cureus. 2024 Feb 19;16(2):e54441. doi: 10.7759/cureus.54441. eCollection 2024 Feb.
A 48-year-old patient with a weight of 120 kg with type 2 diabetes mellitus, hypertension, and gout was hospitalized on the third day of the COVID-19 diagnosis. His general condition is relatively good, oxygen saturation is 89%. Despite starting standard treatment, on the seventh day from the onset of symptoms, the patient deteriorated sharply (oxygen saturation dropped to 74%). The negative development of the disease is interrupted with a loading dose of colchicine of 6 mg. This is a typical case of the life-saving effect of high but safe doses of colchicine in high-risk COVID-19 patients.
一名48岁、体重120公斤的患者,患有2型糖尿病、高血压和痛风,在确诊COVID-19的第三天住院。他的一般状况相对良好,血氧饱和度为89%。尽管开始了标准治疗,但在症状出现后的第七天,患者病情急剧恶化(血氧饱和度降至74%)。给予6毫克秋水仙碱负荷剂量后,病情的不良发展得到了阻断。这是高剂量但安全的秋水仙碱对高危COVID-19患者产生救命效果的典型病例。